Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East

Ibrahim Al-Zakwani, Mohammad Zubaid, Adil Al-Riyami, Muath Alanbaei, Kadhim Sulaiman, Wael Almahmeed, Ahmed Al-Motarreb, Jassim Al Suwaidi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background Little is known about predictors and outcome differences of primary percutaneous coronary intervention (PPCI) and thrombolytic therapy (TT) in ST-segment elevation myocardial infarction (STEMI) patients in the Middle East. Objective To compare predictors as well as in-hospital outcomes of PPCI and TT in STEMI patients in six Middle Eastern countries. Setting Sixty-five hospitals (covering at least 85 % of the population) in Oman, United Arab Emirates, Qatar, Bahrain, Kuwait and Yemen. Methods This was a prospective, multinational, multicentre, observational survey of consecutive acute coronary syndrome patients who were admitted to 65 hospitals during May 8, 2006 to June 6, 2006 and from January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute Coronary Events). Analyses were performed using univariate and multivariate statistical techniques. Main outcome measures Predictors as well as inhospital outcomes of PPCI and TT in STEMI patients. Results Out of 2,155 STEMI patients admitted to hospitals within 12 h of symptoms onset, 92 % received reperfusion (8 % PPCI and 84 % TT). TT use included reteplase (43 %), tenecteplase (30 %), streptokinase (25 %), and alteplase (2 %). Median age of the study cohort was 50 (44-58) years with majority being males (90 %). There were no significant differences in median onset time to presentation between the TT and PPCI groups (130 vs. 120 min; P = 0.422). Median door-to-needle time and door-to-balloon time were 45 min (29-75) and 75 min (58-120), respectively. Predictors of PPCI included prior PCI, hospitals with catheterization laboratory facilities as well as those involved with academia. Multivariate logistic regression model demonstrated that patients that had PPCI were less likely to have recurrent ischemic attacks than those that had TT (odds ratio, 0.18; 95 % CI, 0.06-0.56; P = 0.003). Conclusions The main reperfusion strategy for STEMI patients in the Arab Middle East region is throm-bolytic therapy. Predictors of primary percutaneous coronary intervention included prior percutaneous coronary intervention, hospitals with catheterization laboratory facilities as well as those involved with academia. Primary percutaneous coronary intervention resulted in significant reductions in recurrent ischemic events when compared to thrombolytic therapy.

Original languageEnglish
Pages (from-to)445-451
Number of pages7
JournalInternational Journal of Clinical Pharmacy
Volume34
Issue number3
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Middle East
Thrombolytic Therapy
Percutaneous Coronary Intervention
Myocardial Infarction
Streptokinase
Catheterization
Balloons
Reperfusion
Tissue Plasminogen Activator
Needles
Logistic Models
Bahrain
Qatar
Logistics
Yemen
United Arab Emirates
Oman
Kuwait
Acute Coronary Syndrome
Registries

Keywords

  • Arab Countries
  • Ischemic attack
  • Myocardial infarction
  • Primary angioplasty
  • Thrombolysis

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmaceutical Science
  • Pharmacology
  • Toxicology
  • Pharmacy

Cite this

Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East. / Al-Zakwani, Ibrahim; Zubaid, Mohammad; Al-Riyami, Adil; Alanbaei, Muath; Sulaiman, Kadhim; Almahmeed, Wael; Al-Motarreb, Ahmed; Al Suwaidi, Jassim.

In: International Journal of Clinical Pharmacy, Vol. 34, No. 3, 06.2012, p. 445-451.

Research output: Contribution to journalArticle

Al-Zakwani, Ibrahim ; Zubaid, Mohammad ; Al-Riyami, Adil ; Alanbaei, Muath ; Sulaiman, Kadhim ; Almahmeed, Wael ; Al-Motarreb, Ahmed ; Al Suwaidi, Jassim. / Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East. In: International Journal of Clinical Pharmacy. 2012 ; Vol. 34, No. 3. pp. 445-451.
@article{caa628d8992540a98da77946136a7f61,
title = "Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East",
abstract = "Background Little is known about predictors and outcome differences of primary percutaneous coronary intervention (PPCI) and thrombolytic therapy (TT) in ST-segment elevation myocardial infarction (STEMI) patients in the Middle East. Objective To compare predictors as well as in-hospital outcomes of PPCI and TT in STEMI patients in six Middle Eastern countries. Setting Sixty-five hospitals (covering at least 85 {\%} of the population) in Oman, United Arab Emirates, Qatar, Bahrain, Kuwait and Yemen. Methods This was a prospective, multinational, multicentre, observational survey of consecutive acute coronary syndrome patients who were admitted to 65 hospitals during May 8, 2006 to June 6, 2006 and from January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute Coronary Events). Analyses were performed using univariate and multivariate statistical techniques. Main outcome measures Predictors as well as inhospital outcomes of PPCI and TT in STEMI patients. Results Out of 2,155 STEMI patients admitted to hospitals within 12 h of symptoms onset, 92 {\%} received reperfusion (8 {\%} PPCI and 84 {\%} TT). TT use included reteplase (43 {\%}), tenecteplase (30 {\%}), streptokinase (25 {\%}), and alteplase (2 {\%}). Median age of the study cohort was 50 (44-58) years with majority being males (90 {\%}). There were no significant differences in median onset time to presentation between the TT and PPCI groups (130 vs. 120 min; P = 0.422). Median door-to-needle time and door-to-balloon time were 45 min (29-75) and 75 min (58-120), respectively. Predictors of PPCI included prior PCI, hospitals with catheterization laboratory facilities as well as those involved with academia. Multivariate logistic regression model demonstrated that patients that had PPCI were less likely to have recurrent ischemic attacks than those that had TT (odds ratio, 0.18; 95 {\%} CI, 0.06-0.56; P = 0.003). Conclusions The main reperfusion strategy for STEMI patients in the Arab Middle East region is throm-bolytic therapy. Predictors of primary percutaneous coronary intervention included prior percutaneous coronary intervention, hospitals with catheterization laboratory facilities as well as those involved with academia. Primary percutaneous coronary intervention resulted in significant reductions in recurrent ischemic events when compared to thrombolytic therapy.",
keywords = "Arab Countries, Ischemic attack, Myocardial infarction, Primary angioplasty, Thrombolysis",
author = "Ibrahim Al-Zakwani and Mohammad Zubaid and Adil Al-Riyami and Muath Alanbaei and Kadhim Sulaiman and Wael Almahmeed and Ahmed Al-Motarreb and {Al Suwaidi}, Jassim",
year = "2012",
month = "6",
doi = "10.1007/s11096-012-9627-1",
language = "English",
volume = "34",
pages = "445--451",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Primary coronary intervention versus thrombolytic therapy in myocardial infarction patients in the Middle East

AU - Al-Zakwani, Ibrahim

AU - Zubaid, Mohammad

AU - Al-Riyami, Adil

AU - Alanbaei, Muath

AU - Sulaiman, Kadhim

AU - Almahmeed, Wael

AU - Al-Motarreb, Ahmed

AU - Al Suwaidi, Jassim

PY - 2012/6

Y1 - 2012/6

N2 - Background Little is known about predictors and outcome differences of primary percutaneous coronary intervention (PPCI) and thrombolytic therapy (TT) in ST-segment elevation myocardial infarction (STEMI) patients in the Middle East. Objective To compare predictors as well as in-hospital outcomes of PPCI and TT in STEMI patients in six Middle Eastern countries. Setting Sixty-five hospitals (covering at least 85 % of the population) in Oman, United Arab Emirates, Qatar, Bahrain, Kuwait and Yemen. Methods This was a prospective, multinational, multicentre, observational survey of consecutive acute coronary syndrome patients who were admitted to 65 hospitals during May 8, 2006 to June 6, 2006 and from January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute Coronary Events). Analyses were performed using univariate and multivariate statistical techniques. Main outcome measures Predictors as well as inhospital outcomes of PPCI and TT in STEMI patients. Results Out of 2,155 STEMI patients admitted to hospitals within 12 h of symptoms onset, 92 % received reperfusion (8 % PPCI and 84 % TT). TT use included reteplase (43 %), tenecteplase (30 %), streptokinase (25 %), and alteplase (2 %). Median age of the study cohort was 50 (44-58) years with majority being males (90 %). There were no significant differences in median onset time to presentation between the TT and PPCI groups (130 vs. 120 min; P = 0.422). Median door-to-needle time and door-to-balloon time were 45 min (29-75) and 75 min (58-120), respectively. Predictors of PPCI included prior PCI, hospitals with catheterization laboratory facilities as well as those involved with academia. Multivariate logistic regression model demonstrated that patients that had PPCI were less likely to have recurrent ischemic attacks than those that had TT (odds ratio, 0.18; 95 % CI, 0.06-0.56; P = 0.003). Conclusions The main reperfusion strategy for STEMI patients in the Arab Middle East region is throm-bolytic therapy. Predictors of primary percutaneous coronary intervention included prior percutaneous coronary intervention, hospitals with catheterization laboratory facilities as well as those involved with academia. Primary percutaneous coronary intervention resulted in significant reductions in recurrent ischemic events when compared to thrombolytic therapy.

AB - Background Little is known about predictors and outcome differences of primary percutaneous coronary intervention (PPCI) and thrombolytic therapy (TT) in ST-segment elevation myocardial infarction (STEMI) patients in the Middle East. Objective To compare predictors as well as in-hospital outcomes of PPCI and TT in STEMI patients in six Middle Eastern countries. Setting Sixty-five hospitals (covering at least 85 % of the population) in Oman, United Arab Emirates, Qatar, Bahrain, Kuwait and Yemen. Methods This was a prospective, multinational, multicentre, observational survey of consecutive acute coronary syndrome patients who were admitted to 65 hospitals during May 8, 2006 to June 6, 2006 and from January 29, 2007 to June 29, 2007, as part of Gulf RACE (Registry of Acute Coronary Events). Analyses were performed using univariate and multivariate statistical techniques. Main outcome measures Predictors as well as inhospital outcomes of PPCI and TT in STEMI patients. Results Out of 2,155 STEMI patients admitted to hospitals within 12 h of symptoms onset, 92 % received reperfusion (8 % PPCI and 84 % TT). TT use included reteplase (43 %), tenecteplase (30 %), streptokinase (25 %), and alteplase (2 %). Median age of the study cohort was 50 (44-58) years with majority being males (90 %). There were no significant differences in median onset time to presentation between the TT and PPCI groups (130 vs. 120 min; P = 0.422). Median door-to-needle time and door-to-balloon time were 45 min (29-75) and 75 min (58-120), respectively. Predictors of PPCI included prior PCI, hospitals with catheterization laboratory facilities as well as those involved with academia. Multivariate logistic regression model demonstrated that patients that had PPCI were less likely to have recurrent ischemic attacks than those that had TT (odds ratio, 0.18; 95 % CI, 0.06-0.56; P = 0.003). Conclusions The main reperfusion strategy for STEMI patients in the Arab Middle East region is throm-bolytic therapy. Predictors of primary percutaneous coronary intervention included prior percutaneous coronary intervention, hospitals with catheterization laboratory facilities as well as those involved with academia. Primary percutaneous coronary intervention resulted in significant reductions in recurrent ischemic events when compared to thrombolytic therapy.

KW - Arab Countries

KW - Ischemic attack

KW - Myocardial infarction

KW - Primary angioplasty

KW - Thrombolysis

UR - http://www.scopus.com/inward/record.url?scp=84862993645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862993645&partnerID=8YFLogxK

U2 - 10.1007/s11096-012-9627-1

DO - 10.1007/s11096-012-9627-1

M3 - Article

C2 - 22477207

AN - SCOPUS:84862993645

VL - 34

SP - 445

EP - 451

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 3

ER -